UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018671
Receipt number R000021583
Scientific Title Prospective randomized trial of nutritional support for esophageal patients after esophagectomy
Date of disclosure of the study information 2015/08/14
Last modified on 2016/08/14 13:19:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective randomized trial of nutritional support for esophageal patients after esophagectomy

Acronym

Nutritional support for esophageal patients after esophagectomy

Scientific Title

Prospective randomized trial of nutritional support for esophageal patients after esophagectomy

Scientific Title:Acronym

Nutritional support for esophageal patients after esophagectomy

Region

Japan


Condition

Condition

esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy of Aband for body weight loss in esophageal cancer patients after esophagectomy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Change of body weight 6 months after surgery

Key secondary outcomes

Change of body weight 12 months after surgery, change of body composition 6 and 12 months after surgery


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Take Aband for 3 months after esophagectomy

Interventions/Control_2

No treatment

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Esophageal cancer patients underwent curative esophagectomy and reconstruction with stomach
2. Performance status 0-2
3. No serious abnormality in heart, lung, bone marrow, liver, and renal functions

Key exclusion criteria

1. Severe postoperative complications
2. Scheduled to receive postoperative adjuvant therapy

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keijiro Sugimura

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Department of Surgery

Zip code


Address

1-3-3 Higashinari-ku, Osaka

TEL

06-6972-1181

Email

sugimura-ke@mc.pref.osaka.jp


Public contact

Name of contact person

1st name
Middle name
Last name Keijiro Sugimura

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Department of Surgery

Zip code


Address

1-3-3 Higashinari-ku, Osaka

TEL

06-6972-1181

Homepage URL


Email

sugimura-ke@mc.pref.osaka.jp


Sponsor or person

Institute

Osaka Medical Center for Cancer and Cardiovascular Diseases

Institute

Department

Personal name



Funding Source

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪府立成人病センター
大阪府立急性期・総合医療センター


Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2013 Year 05 Month 15 Day

Date of IRB


Anticipated trial start date

2013 Year 05 Month 15 Day

Last follow-up date

2016 Year 12 Month 31 Day

Date of closure to data entry

2016 Year 12 Month 31 Day

Date trial data considered complete

2017 Year 01 Month 30 Day

Date analysis concluded

2017 Year 03 Month 22 Day


Other

Other related information



Management information

Registered date

2015 Year 08 Month 14 Day

Last modified on

2016 Year 08 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021583


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name